< BACK TO PRESS RELEASES LISTING
Monday, June 4, 2018
HOULIHAN LOKEY STRENGTHENS PHARMACEUTICAL AND LIFE SCIENCES VALUATION CAPABILITIES WITH NEW HIRE
Dimitri Drone Joins Firm as a
Managing Director in New York
NEW YORK – June 4, 2018 – Houlihan
Lokey (NYSE:HLI), the global investment bank, today announced that Dimitri
Drone has joined the firm as a Managing Director in Financial Advisory Services
as part of a continued build-out of the firm’s pharmaceutical & life sciences
valuation services. Mr. Drone is based in New York and will advise clients on
valuation, financial, and transaction matters across the spectrum of healthcare
and life sciences.
Prior to joining Houlihan Lokey, Mr.
Drone was the global leader of PwC’s Deals business for the pharmaceutical &
life sciences sector. During his nearly 30-year tenure with PwC, he advised
corporate and private equity clients on the structuring of complex merger &
acquisition transactions, alliances, partnerships, and joint ventures, as well
as minority investments to address financial reporting, corporate finance, and
valuation issues. Mr. Drone is a leading advisor to clients on valuation
principles, methodologies, and critical assumptions employed in various
business enterprise, intangible asset, and security valuation exercises. He has
also served clients across the spectrum of life science industries, including
pharmaceuticals, biotech, medical device, diagnostics, generics, consumer,
animal health, and contract research organizations.
“As we continue to assist corporate
and financial clients across the healthcare continuum in increasingly challenging
and global transactions, we are seeking established expertise with leading
companies around the world. Welcoming Dimitri to the Houlihan Lokey team
continues our industry growth strategy and commitment to providing market-leading
valuation and transaction advisory services to pharmaceutical & life sciences
companies and investors,” said Jack Berka, Senior Managing Director and Global Head
of Financial Advisory Services.
“It’s a privilege to join the Houlihan Lokey team
with its long-standing reputation in valuing complex, emerging, and technology-based
businesses and assets. I am looking forward to leveraging my experience serving
multinational corporate clients in a commercial and transaction driven culture,”
said Mr. Drone.
Mr. Drone holds a B.S. in Accounting
from Bucknell University and an MBA in Finance and Economics from the University
of Chicago’s Booth School of Business. He is a licensed Certified Public
Accountant and Chartered Financial Analyst®.
Houlihan Lokey (NYSE:HLI) is a global investment bank with expertise in mergers and acquisitions, capital markets, financial restructuring, valuation, and strategic consulting. The firm serves corporations, institutions, and governments worldwide with offices in the United States, Europe, the Middle East, and the Asia-Pacific region. Independent advice and intellectual rigor are hallmarks of the firm's commitment to client success across its advisory services. Houlihan Lokey is ranked as the No. 1 M&A advisor for all U.S. transactions, the No. 1 global restructuring advisor, and the No. 1 global M&A fairness opinion advisor over the past 20 years, according to Thomson Reuters.
For press inquiries, contact
PR@HL.com or 212.331.8223.